Jump to navigation
At this symposium, 20 internationally renowned experts from North America, Europe and Asia provided updates and highlighted imminent developments in the diagnosis and treatment of pleuropulmonary disease for the 21st century.
Join the only international association solely dedicated to lung cancer research and treatment.
The IASLC’s premier journal, emphasizing a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews and opinion pieces.Member JTO Access
IASLC 40th Anniversary Page